• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Odinwell

0.20 SEK

-0.99 %

Less than 1K followers

ODIN

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.99 %
-13.04 %
+4.99 %
+11.42 %
-9.09 %
-45.65 %
-87.29 %
-96.80 %
-96.77 %

Odinwell operates in the medical technology sector. The company specializes in the development of medical technology products for wound care. The company develops a platform for wound care with associated technological aids to analyze and facilitate the process of difficult-to-heal wounds. In addition to its main business, service and associated ancillary services are also offered. The business is conducted in Sweden with headquarters in Halmstad.

Read more
Market cap
11.02M SEK
Turnover
8.56K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
23/6
2026

Extraordinary general meeting '26

18/8
2026

Interim report Q2'26

17/11
2026

Interim report Q3'26

Regulatory press release6/4/2026, 6:00 AM

Kallelse till extra bolagsstämma i Odinwell AB

Odinwell
Regulatory press release6/2/2026, 4:24 PM

Odinwell offentliggör utfall i utnyttjande av teckningsoptioner TO 2

Odinwell
Press release6/1/2026, 8:21 AM

Odinwell AB erhåller ytterligare teckningsförbindelser inför inlösen av teckningsoptioner av serie TO2

Odinwell

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release5/28/2026, 6:37 AM

Sista dag för handel med teckningsoptioner av serie TO 2 i Odinwell

Odinwell
Regulatory press release5/27/2026, 4:07 PM

Kommuniké från årsstämma i Odinwell AB (publ) den 27 maj 2026

Odinwell
Regulatory press release5/27/2026, 6:30 AM

Odinwell AB (publ.) Delårsrapport Q1 2026

Odinwell
Regulatory press release5/15/2026, 4:22 PM

Teckningskursen för teckningsoptioner av serie TO 2 i Odinwell har fastställts till 0,164 SEK per aktie inför teckningsperioden som inleds på måndag den 18 maj 2026

Odinwell
Press release5/7/2026, 2:44 PM

Odinwell får beställning på två handhållna instrument

Odinwell
Regulatory press release4/30/2026, 8:20 AM

Odinwell: Publicering av årsredovisning 2025

Odinwell
Press release4/27/2026, 6:30 AM

Rättelse: Styrelseledamöter och ledningen, samt huvudägaren, har åtagit sig att nyttja sina teckningsoptioner av serie TO 2 i Odinwell

Odinwell
Press release4/24/2026, 3:44 PM

Styrelseledamöter och ledningen, samt huvudägaren, har åtagit sig att nyttja sina teckningsoptioner av serie TO 2 i Odinwell

Odinwell
Regulatory press release4/23/2026, 6:13 AM

Kallelse till Årsstämma i Odinwell AB (publ)

Odinwell
Press release3/31/2026, 12:32 PM

Pilotproduktion påbörjad och veterinärmedicin integreras i Odinwells utvecklingsplan

Odinwell
Regulatory press release2/11/2026, 7:30 AM

Odinwell AB (publ.) Bokslutskommuniké Q4 2025

Odinwell
Press release1/8/2026, 9:21 AM

Odinwell inleder innovationsuppdrag för kund

Odinwell
Regulatory press release12/22/2025, 12:18 PM

Kommuniké från extra bolagsstämma i Odinwell AB (publ) den 22 december 2025

Odinwell
Regulatory press release12/8/2025, 12:48 PM

Odinwells optionslösen är registrerad - omvandling av interimsaktier till aktier

Odinwell
Regulatory press release12/3/2025, 9:14 AM

Extra Bolagsstämma i Odinwell AB (publ)

Odinwell
Regulatory press release12/3/2025, 9:10 AM

Odinwell offentliggör utfall i utnyttjande av teckningsoptioner TO 1 och föreslår riktad nyemission till garanter

Odinwell
Press release11/28/2025, 7:00 AM

Sista dag för handel med teckningsoptioner av serie TO 1 i Odinwell

Odinwell